Dr. Huma Qamar Emerges as a Pivotal Leader in Rare Disease Research and Public Health Strategy

Dr. Huma Qamar, MD, MPH, CMI, continues to gain national recognition for her work at the intersection of clinical innovation, public health, and inclusive leadership. Currently serving as Chief Medical Officer at Ocugen, Inc. (NASDAQ: OCGN), Dr. Qamar is leading efforts to bring forward groundbreaking treatments for rare retinal diseases,...

Going Global: Groves Capital Poised to Become a Leader in Domestic and International Commercial Lending

In the fast-paced realm of financial services, adaptability is the name of the game for sustained success. Recognized as a beacon of reliability and trust in lending, Groves Capital is making headlines with its strategic pivot.  With a keen eye on market trends and a commitment to innovation, the company...